Literature DB >> 35146589

A cross-sectional survey of genetic counselors providing carrier screening regarding GBA variants and Parkinson disease susceptibility.

Tara A Jones1, Jeanine Schulze2, Sharon Aufox1, Jason Rothstein3, Aishwarya Arjunan4.   

Abstract

PURPOSE: Adult-onset disease risks associated with carriers of recessive disease have and will continue to be identified. As carrier screening becomes more broadly utilized, providers face the dilemma of whether they should discuss these risks during discussions with prospective parents. This study aimed to understand whether preconception/prenatal genetic counselors (PPGCs) were aware of the risk of Parkinson disease in carriers of, and persons with, Gaucher disease and the reasons behind choosing whether to discuss this risk with patients.
METHODS: Eligible participants included board-certified or board-eligible genetic counselors who had counseled preconception/prenatal patients within the past 3 years. An online survey was distributed via the National Society of Genetic Counselors in November of 2017.
RESULTS: One hundred twenty genetic counselors completed the quantitative survey, distributed in Fall of 2017. While the majority of respondents knew of the Gaucher-related Parkinson's link (n = 78; 65%), just over one-third reported discussing it in preconception/prenatal settings (n = 30; 38.5%). Respondents reported discussing these links more consistently when disclosing positive results or when the patient/family approached the topic. Respondents cited the lack of professional guidelines as one of the main reasons for not discussing the link.
CONCLUSION: These results highlight an inconsistency in PPGCs' discussions of the Parkinson's risk in Gaucher disease carriers, and the need to develop guidelines regarding these issues to help standardize the care and education of patients.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carrier risks; Carrier screening; Informed consent; Pregnancy; Prenatal testing; Secondary findings

Mesh:

Year:  2022        PMID: 35146589      PMCID: PMC8995214          DOI: 10.1007/s10815-022-02430-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  32 in total

1.  Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel.

Authors:  Sari Lieberman; Shachar Zuckerman; Ephrat Levy-Lahad; Gheona Altarescu
Journal:  Am J Med Genet A       Date:  2011-08-10       Impact factor: 2.802

2.  Knowledge and attitudes towards genetic testing in those affected with Parkinson's disease.

Authors:  Tracey M Scuffham; Aideen McInerny-Leo; Shu-Kay Ng; George Mellick
Journal:  J Community Genet       Date:  2013-09-10

3.  Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.

Authors:  Lauren Bogue; Holly Peay; Ann Martin; Ann Lucas; Sindhu Ramchandren
Journal:  Neuromuscul Disord       Date:  2016-09-16       Impact factor: 4.296

Review 4.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

5.  Differential effects of severe vs mild GBA mutations on Parkinson disease.

Authors:  Ziv Gan-Or; Idan Amshalom; Laura L Kilarski; Anat Bar-Shira; Mali Gana-Weisz; Anat Mirelman; Karen Marder; Susan Bressman; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurology       Date:  2015-02-04       Impact factor: 9.910

6.  Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling.

Authors:  Huma Q Rana; Manisha Balwani; Louise Bier; Roy N Alcalay
Journal:  Genet Med       Date:  2012-08-30       Impact factor: 8.822

7.  Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Anthony R Gregg; Mahmoud Aarabi; Susan Klugman; Natalia T Leach; Michael T Bashford; Tamar Goldwaser; Emily Chen; Teresa N Sparks; Honey V Reddi; Aleksandar Rajkovic; Jeffrey S Dungan
Journal:  Genet Med       Date:  2021-07-20       Impact factor: 8.864

8.  ACMG position statement on prenatal/preconception expanded carrier screening.

Authors:  Wayne W Grody; Barry H Thompson; Anthony R Gregg; Lora H Bean; Kristin G Monaghan; Adele Schneider; Roger V Lebo
Journal:  Genet Med       Date:  2013-04-25       Impact factor: 8.822

Review 9.  Fragile X-Associated Neuropsychiatric Disorders (FXAND).

Authors:  Randi J Hagerman; Dragana Protic; Akash Rajaratnam; Maria J Salcedo-Arellano; Elber Yuksel Aydin; Andrea Schneider
Journal:  Front Psychiatry       Date:  2018-11-13       Impact factor: 4.157

10.  What women want: General population perspectives and access to preconception expanded carrier screening.

Authors:  Liya Rabkina; Amy Swanson; Sharon Aufox; Lauren Propst; Morris Fiddler; Andrew Wagner; Aishwarya Arjunan
Journal:  Prenat Diagn       Date:  2021-07-01       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.